ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2023
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Companies News

Q3FY17: Dr Reddy's Laboratories' net profit down 19% at Rs 470 crore

GV Prasad, Co-chairman of Dr Reddy's Laboratories said, "Our performance in Q3 has delivered a modest sequential revenue growth of 3% over the previous quarter. Our EBITDA has improved significantly from the last quarter to Rs 8.8 billion, on the back of enhanced emphasis on operational efficiencies and controlling of SG&A cost across all our business."

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Q3FY17: Dr Reddy's Laboratories' net profit down 19% at Rs 470 crore
Dr Reddy reported consolidated net profit of Rs 470.1 crore in Q3, down by 8.83% from Rs 579.2 crore in the corresponding period of the previous year. Photo: Pixabay

Dr Reddy's Laboratories reported 19% year-on-year (YoY) decline in consolidated net profit for its third quarter ended December 31, 2016. 

The company reported consolidated net profit of Rs 470.1 crore in Q3, down by 18.83% from Rs 579.2 crore in the corresponding period of the previous year. 

Consolidated total income from operations stood at Rs 3706.5 crore, also witnessing decline of 6.58% compared to Rs 3910 crore a year ago same period. 

Operating profit (EBITDA) was at Rs 879.3 crore, decreasing by 13.06% year-on-year (YoY). While EBITDA margin was at 23.7%, contracting by 180 basis points yoy. 

GV Prasad, Co-chairman of Dr Reddy's Laboratory said, "Our performance in Q3 has delivered a modest sequential revenue growth of 3% over the previous quarter. Our EBITDA has improved significantly from the last quarter to Rs 8.8 billion, on the back of enhanced emphasis on operational efficiencies and controlling of SG&A cost across all our business."

This Q3, revenue from global generics (GG) stood at Rs 3060 crore, which was down by 9%. The company said, "This was primarily on account of lower contribution from North America and Venezuela. However it grew by 6% sequentially."

Revenue from North America was at Rs 1660 crore, declining by 15% yoy respectively.

As of December 31, 2016, Dr Reddy had cumulatively 92 generic filings pending for approval from the USFDA. 

Going ahead, revenue from emerging market was at Rs 590 crore, also down by 7%. 

While revenue from India rose by 2.4% yoy at Rs 590 crore and that of Europe at Rs 210 crore increasing by 11%. 

Share price of Dr Reddy closed at Rs 3141.60 a piece, above Rs 45.45 or 1.47%.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Dr Reddy's LaboratoriesDr Reddy's Laboratories Q3 resultSharesMarketBSEpharmaceuticalQ3FY17financial performanceUSFDA
Written By: ZeeBiz WebTeam
Updated: Sat, Feb 04, 2017
03:02 pm
Mumbai, ZeeBiz WebDesk
RELATED NEWS
Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today
Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug
Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022 Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022
Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow
Dr Reddy's, Sun Pharma recall products in US for manufacturing issues Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

LATEST NEWS

Stock Split: This small-cap company splits shares in 5:1 ratio after delivering 817% return in 5 years

Vani Jayaram songs list in Telugu, Malayalam and Kannada: Remembering veteran playback singer who sung over 10,000 songs

Q3 Results 2023: Paytm narrows loss, IndiGo's net profit soars to Rs 1,422.6 crore

ITC Dividend 2023: Check record date, ex-date and payment date | ITC Share Price NSE Target

Kiara Advani and Sidharth Malhotra wedding: Bride-to-be arrives at marriage venue in Jaisalmer

Pakistan's rupee continues speedy crash against US dollar, suffers another big fall

Vani Jayaram, veteran playback singer, dies at 77

PIB Fact Check unearths truth behind this viral letter on PM Mudra loan scheme; have you also received any such post?

Gold Price Today (February 4): Yellow metal dips over Rs 2,500 from record high - Check rate in Delhi, Mumbai and other cities

Market Next Week: Tata Steel, Hero Moto, M&M results, RBI policy meeting, macro data, global cues among top cues for D-Street

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. India Dot Com Private Limited. All Rights Reserved.
LIVE TV